Tested after a gym day, the Salonpas Pain Relief Patch delivered cooling-warming comfort and targeted relief. Here’s my full review, rating, and which Salonpas is best for you I’ve been in a slow-burn ...

FLORHAM PARK, NJ / ACCESS Newswire / April 30, 2025 / Hisamitsu America, the marketers of Salonpas®, the world's No.1 Brand of Over-the-Counter (OTC) topical analgesics in the patch category4, is ...

FLORHAM PARK, NJ / ACCESSWIRE / May 1, 2024 / In celebration of the 90 th anniversary of the Salonpas® patch, the world's No.1 Brand of Over-the-Counter (OTC) topical analgesics in the patch category, ...

"Salonpas is more than a pain relief patch; it's a symbol of time-tested, trusted medicine that transcends generations," said Bob Arnot, M.D., internal medicine who is a journalist, author and served ...

Hisamitsu Pharmaceutical Co., Inc., founded in 1847, is a global pioneer and innovator of transdermal and topical patch technology with a focus on pain relief. The Salonpas® product line, which gained ...

Global healthcare company, Hisamitsu Pharmaceutical Co. Inc., has launched Salonpas products, which are alternatives to injections and capsules for pain. Executive Officer and Head of the ...

HRG reviewed 12 products in the health category, 125 items in the wellness sector and 92 products in the beauty aisle to see ...

Hisamitsu Pharmaceutical Co. is considering a takeover bid to privatize the Japanese maker of pain-relief patches in a deal that could be valued at about ¥450 billion ($2.9 billion), according to ...

The two ads, one featuring an office lady and the other a minibus driver, seek to raise awareness of Salonpas, with a light-hearted depiction of an aching muscle calling out repeatedly for the patch ...

Hisamitsu Pharmaceutical Co. is set to climb to its daily trading limit for a second day after the Japanese maker of pain-relief patches announced it would go private in a management buyout valued at ...

Hisamitsu, known for its Salonpas pain-relief patches, joins a growing list of Japanese companies exiting the public market. (Jan 6): Hisamitsu Pharmaceutical Co’s management is considering a takeover ...